Mutants blocked or altered at different steps in the synthesis, assembly, or secretion of Ig by mouse myeloma cells have been isolated and are being characterized. In addition, we have established methods for transfecting Ig genes into lymphoid cells and having them expressed. We are now using these methods to explore Ig gene and protein function. We have prepared a transfection vector that contains the entire MPC-11 gamma?2b? gene. Experiments have shown that, when this gene is transfected into lymphoma cells, the predominant mRNA made is of the membrane type; when we transfect this gene into myeloma cell, the predominant mRNA is of the secreted form. We have used this gene to identify sequences 3' of the gamma?2b? gene which are important for its polyadenylation and processing to the mRNA encoding the secreted immunoglobulin. We have also used gene transfection to construct and express novel Ig molecules. We have joined the variable region from the heavy chain to the light chain constant region and have produced light chain heterodimers which bind antigen. In addition the variable region from a mouse myeloma has been joined to human constant region genes. When these genes are transfected a chimeric protein is produced with the variable regions and specificity of the mouse myeloma joined to the human constant region with its associated effector functions. We also have reconstructed and expressed a heavy chain which is completely human. We are now beginning to construct chimeric molecules of novel structure and will investigate their biologic functon. The chimeric molecules have wide potential applicaion in diagnostics and therapy. (AB)

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Immunobiology Study Section (IMB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Schools of Medicine
New York
United States
Zip Code
Choi, Sung Hee; Kim, Byung-Gyu; Robinson, Janet et al. (2014) Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. J Clin Invest 124:2472-82
Montano, Ramon F; Penichet, Manuel L; Blackall, Douglas P et al. (2009) Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. J Immunol Methods 340:1-10
Gala, Francoise A; Morrison, Sherie L (2004) V region carbohydrate and antibody expression. J Immunol 172:5489-94
Gala, Francoise A; Morrison, Sherie L (2002) The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. J Biol Chem 277:29005-11
Helguera, G; Morrison, S L; Penichet, M L (2002) Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy. Clin Immunol 105:233-46
Montano, Ramon F; Morrison, Sherie L (2002) Influence of the isotype of the light chain on the properties of IgG. J Immunol 168:224-31
Penichet, M L; Morrison, S L (2001) Antibody-cytokine fusion proteins for the therapy of cancer. J Immunol Methods 248:91-101
Trinh, K R; Morrison, S L (2000) Site-specific and directional gene replacement mediated by Cre recombinase. J Immunol Methods 244:185-93
Chan, L A; Lyczak, J B; Zhang, K et al. (2000) The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Mol Immunol 37:241-52
Mateo, C; Lombardero, J; Moreno, E et al. (2000) Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. Hybridoma 19:463-71

Showing the most recent 10 out of 100 publications